Clinical Trial Update: A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on the effectiveness of off-label mefloquine for treating viral pneumonia and respiratory failure in COVID-19 patients (Phase 2/Phase 3;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia Viral
• Respiratory Failure

Drugs mentioned

• Mefloquine (Mefloquine)

Snippet

Sponsor: Burnasyan Federal Medical Biophysical Center | Conditions: Pneumonia, Viral, Respiratory Failure | Phase 2, Phase 3 | Status: COMPLETED